Analysts See $0.00 EPS for Fanhua (ADR) (FANH); Shorts at Laboratory America Holdings (LH) Lowered By 8.15%

Analysts expect Fanhua Inc (ADR) (NASDAQ:FANH) to report $0.00 EPS on May, 22 after the close. About 20,604 shares traded. Fanhua Inc (ADR) (NASDAQ:FANH) has risen 2.86% since September 30, 2016 and is uptrending. It has underperformed by 7.80% the S&P500.

Laboratory Corporation America Holdings (NYSE:LH) had a decrease of 8.15% in short interest. LH’s SI was 2.73 million shares in May as released by FINRA. Its down 8.15% from 2.98M shares previously. With 657,900 avg volume, 4 days are for Laboratory Corporation America Holdings (NYSE:LH)’s short sellers to cover LH’s short positions. The SI to Laboratory Corporation America Holdings’s float is 2.68%. About 59,879 shares traded. Laboratory Corp. of America Holdings (NYSE:LH) has risen 3.43% since September 30, 2016 and is uptrending. It has underperformed by 7.23% the S&P500.

Fanhua Inc., formerly CNinsure Inc., is an independent online-to-offline financial services well-known provider in China. The company has market cap of $453.27 million. The Firm distributes a range of property, casualty and life insurance products underwritten by domestic and foreign insurance companies operating in China to individual and institutional customers, and provides insurance claims adjusting services. It has a 21.18 P/E ratio. The Company’s divisions include insurance agency, which provides a range of property, casualty and life insurance products to individual customers; insurance brokerage, which provides commercial lines of property and casualty insurance, group life insurance programs and risk management consulting services to businesses and reinsurance brokerage services to insurance companies, and claims adjusting, which provides claims adjusting services to self-insured entities or insurance companies that choose to outsource some or all of their claims adjustment functions.

Laboratory Corporation of America Holdings is a life sciences firm that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The company has market cap of $14.55 billion. The Firm operates as a healthcare diagnostics company. It has a 19.6 P/E ratio. The Firm operates through two divisions: LabCorp Diagnostics and Covance Drug Development (CDD).

Among 12 analysts covering Laboratory Corp (NYSE:LH), 5 have Buy rating, 0 Sell and 7 Hold. Therefore 42% are positive. Laboratory Corp had 21 analyst reports since July 29, 2015 according to SRatingsIntel. KeyBanc Capital Markets maintained it with “Overweight” rating and $150 target in Tuesday, August 16 report. The stock of Laboratory Corp. of America Holdings (NYSE:LH) earned “Buy” rating by Zacks on Monday, August 17. As per Wednesday, July 29, the company rating was maintained by Mizuho. The company was downgraded on Tuesday, December 8 by Goldman Sachs. The firm has “Overweight” rating given on Tuesday, April 26 by Barclays Capital. The rating was downgraded by Robert W. Baird on Monday, February 6 to “Neutral”. The stock of Laboratory Corp. of America Holdings (NYSE:LH) has “Neutral” rating given on Tuesday, April 26 by UBS. The firm earned “Hold” rating on Tuesday, April 26 by Jefferies. RBC Capital Markets maintained Laboratory Corp. of America Holdings (NYSE:LH) on Friday, February 19 with “Sector Perform” rating. Canaccord Genuity maintained the shares of LH in report on Tuesday, April 26 with “Buy” rating.

Investors sentiment increased to 1.02 in Q4 2016. Its up 0.01, from 1.01 in 2016Q3. It is positive, as 48 investors sold Laboratory Corp. of America Holdings shares while 220 reduced holdings. 76 funds opened positions while 197 raised stakes. 92.34 million shares or 0.26% less from 92.58 million shares in 2016Q3 were reported. Weybosset Mngmt Ltd Co holds 25,977 shares or 2.34% of its portfolio. Wisconsin-based Mason Street Advsr Lc has invested 0.05% in Laboratory Corp. of America Holdings (NYSE:LH). Pnc Fincl Serv invested 0.01% of its portfolio in Laboratory Corp. of America Holdings (NYSE:LH). Synovus accumulated 1,225 shares. Quantum Cap Mngmt has 1.72% invested in Laboratory Corp. of America Holdings (NYSE:LH). Chieftain Cap Inc has 4.96% invested in Laboratory Corp. of America Holdings (NYSE:LH) for 775,505 shares. Teachers Retirement System Of The State Of Kentucky holds 0.15% or 92,968 shares. Norinchukin Bancorp The holds 0.02% or 6,248 shares. Blackrock Grp Limited has invested 0.06% in Laboratory Corp. of America Holdings (NYSE:LH). Veritas Invest Management Llp invested 1.83% of its portfolio in Laboratory Corp. of America Holdings (NYSE:LH). Essex Financial Svcs, a Connecticut-based fund reported 7,196 shares. Weitz Invest Incorporated reported 778,751 shares stake. Fdx reported 0.09% stake. Fifth Third Bancorp invested 0.02% of its portfolio in Laboratory Corp. of America Holdings (NYSE:LH). Gideon Capital Advisors stated it has 0.13% in Laboratory Corp. of America Holdings (NYSE:LH).

Since February 23, 2017, it had 0 insider purchases, and 3 insider sales for $1.36 million activity. ANDERSON KERRII B had sold 1,992 shares worth $278,880. Shares for $756,258 were sold by MITTELSTAEDT ROBERT E JR on Friday, February 24. Another trade for 2,300 shares valued at $327,690 was made by EISENBERG GLENN A on Thursday, March 9.